en
E-mail us
+1-609-604-8303
bd_global@crystalpharmatech.com
 cn
Parameter Sensitivity with GastroPlus
Case Studies
10 Jul 2024
Parameter Sensitivity with GastroPlus
ADME Simulations: Insights into Bioavailability and Pharmacokinetics
Case Studies
10 Jul 2024
ADME Simulations: Insights into Bioavailability and Pharmacokinetics
Assessment of CQA in mRNA-LNP Modality
Case Studies
09 Jul 2024
Assessment of CQA in mRNA-LNP Modality
Case Study 3: Atorvastatin - Crystalline Form Change In Late Development
Case Studies
13 Jul 2022
Case Study 3: Atorvastatin - Crystalline Form Change In Late Development
Case Study 5: Lifecycle Management - Olanzapine - Crystalline Change From Free Acid to Salt
Case Studies
13 Jul 2022
Case Study 5: Lifecycle Management - Olanzapine - Crystalline Change From Free Acid to Salt
Case Study 6: Oxybutynin- Crystalline Change From Salt to Free Base
Case Studies
13 Jul 2022
Case Study 6: Oxybutynin- Crystalline Change From Salt to Free Base
Case Study 4: Gatifloxacin - Crystalline Form Changes With A Licensed Compound
Case Studies
13 Jul 2022
Case Study 4: Gatifloxacin - Crystalline Form Changes With A Licensed Compound
Case Study 2: DPC 961 – Form Change On A Fast Track Compound
Case Studies
13 Jul 2022
Case Study 2: DPC 961 – Form Change On A Fast Track Compound
Case Study 1: Indinavir - Early Salt Form Change
Case Studies
22 Mar 2016
Case Study 1: Indinavir - Early Salt Form Change
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Technology
Quick Links
About Us Events
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Sitemap
Privacy Policy
API Form and Solid-State Research
Solid Form Screening and Selection Single Crystal Growth & Structure Determination Solid-State NMR Analysis
Analytical Chemistry
Pre-formulation Studies
Formulation Development
Clinical and Commercial Manufacturing
Technology
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
About Us Technical Articles Events
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303
Sitemap
Privacy Policy